Cargando…

Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark

INTRODUCTION: Pre-diabetes increases the risk of type 2 diabetes, but data are sparse on predictors in a population-based clinical setting. We aimed to develop and validate prediction models for 5-year risks of progressing to type 2 diabetes among individuals with incident HbA1c-defined pre-diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nicolaisen, Sia K, Thomsen, Reimar W, Lau, Cathrine J, Sørensen, Henrik T, Pedersen, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Epidemiology/Health services research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486231/ https://www.ncbi.nlm.nih.gov/pubmed/36113888 http://dx.doi.org/10.1136/bmjdrc-2022-002946

Ejemplares similares

Cohort profile: the Funen Diabetes Database—a population-based cohort of patients with diabetes in Denmark
por: Adelborg, Kasper, et al.
Publicado: (2020)

Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study
por: Skriver, Mette V, et al.
Publicado: (2015)

HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients
por: Zhao, Wenhui, et al.
Publicado: (2014)

HbA(1c) as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial
Publicado: (2015)

Undiagnosed diabetes based on HbA(1c) by socioeconomic status and healthcare consumption in the Tromsø Study 1994–2016
por: Ruiz, Paz Lopez-Doriga, et al.
Publicado: (2021)

Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication
por: Tan, Xiao, et al.
Publicado: (2020)

Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014)

Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort
por: Christensen, Diana Hedevang, et al.
Publicado: (2022)

Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study
por: Knudsen, Jakob S., et al.
Publicado: (2022)

Diabetes, Glycemic Control, and Risk of Hospitalization With Pneumonia: A population-based case-control study
por: Kornum, Jette B., et al.
Publicado: (2008)

Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
por: Edqvist, Jon, et al.
Publicado: (2021)

The Impact of Carbamylation and Anemia on HbA(1c)’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease
por: Tang, Mengyao, et al.
Publicado: (2023)

Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997–2017: Time trends in incidence and HbA(1c) and glucose‐lowering drug use before and after hypoglycaemia
por: Bengtsen, Mads Bisgaard, et al.
Publicado: (2021)

Derivation and external validation of a clinical version of the German Diabetes Risk Score (GDRS) including measures of HbA1c
por: Mühlenbruch, Kristin, et al.
Publicado: (2018)

Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study
por: Barron, Emma, et al.
Publicado: (2020)

New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
por: Lu, Yunxia, et al.
Publicado: (2015)

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USA
por: Pagán, Lorissa, et al.
Publicado: (2023)

Glycated hemoglobin (HbA1c) as diagnostic criteria for diabetes: the optimal cut-off points values for the Pakistani population; a study from second National Diabetes Survey of Pakistan (NDSP) 2016–2017
por: Basit, Abdul, et al.
Publicado: (2020)

Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996–2016
por: Carstensen, Bendix, et al.
Publicado: (2020)

Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional study
por: Hodel, Nikolai Carl, et al.
Publicado: (2020)

Type 2 diabetes medication and HbA1c levels in North Karelia Finland, 2013–2019
por: Wikström, Katja, et al.
Publicado: (2022)

Hospital Records of Pain, Fatigue, or Circulatory Symptoms in Girls Exposed to Human Papillomavirus Vaccination: Cohort, Self-Controlled Case Series, and Population Time Trend Studies
por: Thomsen, Reimar Wernich, et al.
Publicado: (2020)

Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study
por: Petersen, Irene, et al.
Publicado: (2020)

Effect of the interaction between physical activity and estimated macronutrient intake on HbA1c: population-based cross-sectional and longitudinal studies
por: Furukawa, Takuma, et al.
Publicado: (2022)

Components of diabetes prevalence in Denmark 1996–2016 and future trends until 2030
por: Carstensen, Bendix, et al.
Publicado: (2020)

Four‐year HbA1c and LDL‐cholesterol trajectories among individuals with mental disorders and newly developed type 2 diabetes
por: Kristensen, Frederik P., et al.
Publicado: (2021)

Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromsø Study 1994–2016
por: Langholz, Petja Lyn, et al.
Publicado: (2021)

Association and Familial Coaggregation of Type 1 Diabetes and Eating Disorders: A Register-Based Cohort Study in Denmark and Sweden
por: Tate, Ashley E., et al.
Publicado: (2021)

Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996–2016
por: Carstensen, Bendix, et al.
Publicado: (2021)

Neighborhood walkability and pre-diabetes incidence in a multiethnic population
por: Fazli, Ghazal S, et al.
Publicado: (2020)

Healthcare resource utilisation and cost associated with elevated potassium levels: a Danish population-based cohort study
por: Kim, Kun, et al.
Publicado: (2019)

Associations between adolescent experiences, parent experiences and HbA1c: results following two surveys based on the Norwegian Childhood Diabetes Registry (NCDR)
por: Iversen, Hilde Hestad, et al.
Publicado: (2019)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Systemic glucocorticoid use in Denmark: a population-based prevalence study
por: Laugesen, Kristina, et al.
Publicado: (2017)

Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients — A population-based cohort study
por: Adelborg, Kasper, et al.
Publicado: (2019)

Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes: A Danish Population‐Based Cohort Study
por: Thomsen, Reimar Wernich, et al.
Publicado: (2018)

A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark
por: Chang, E T, et al.
Publicado: (2011)

Determinants of physical activity among 6856 individuals with diabetes: a nationwide cross-sectional study
por: Mortensen, Sofie Rath, et al.
Publicado: (2022)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bn7k9fa2092gqpicvdhe9ckun5